These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


287 related items for PubMed ID: 16242254

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma: Phase I-II dose-escalation study.
    Morganti AG, Valentini V, Macchia G, Mattiucci GC, Costamagna G, Deodato F, Smaniotto D, Luzi S, Balducci M, Barbi S, Perri V, Trodella L, Cellini N.
    Int J Radiat Oncol Biol Phys; 2004 Aug 01; 59(5):1454-60. PubMed ID: 15275732
    [Abstract] [Full Text] [Related]

  • 5. Clinical efficacy of brachytherapy combined with external-beam radiotherapy and repeated arterial infusion chemotherapy in patients with unresectable extrahepatic bile duct cancer.
    Nomura M, Yamakado K, Nomoto Y, Nakatsuka A, Ii N, Shoji K, Takeda K.
    Int J Oncol; 2002 Feb 01; 20(2):325-31. PubMed ID: 11788896
    [Abstract] [Full Text] [Related]

  • 6. Chemoradiation of unresectable pancreatic carcinoma: impact of pretreatment hemoglobin level on patterns of failure.
    Morganti AG, Forni F, Macchia G, Valentini V, Smaniotto D, Trodella L, Balducci M, Cellini N.
    Strahlenther Onkol; 2003 Feb 01; 179(2):87-92. PubMed ID: 12590318
    [Abstract] [Full Text] [Related]

  • 7. Relief of jaundice by external beam radiotherapy and intraluminal brachytherapy in patients with extrahepatic cholangiocarcinoma: results without stenting.
    Ishii H, Furuse J, Nagase M, Kawashima M, Ikeda H, Yoshino M.
    Hepatogastroenterology; 2004 Feb 01; 51(58):954-7. PubMed ID: 15239222
    [Abstract] [Full Text] [Related]

  • 8. Treatment of unresectable pancreatic carcinoma by intraluminal brachytherapy in the duct of Wirsung.
    Mutignani M, Shah SK, Morganti AG, Perri V, Macchia G, Costamagna G.
    Endoscopy; 2002 Jul 01; 34(7):555-9. PubMed ID: 12170409
    [Abstract] [Full Text] [Related]

  • 9. Combined external beam and intraluminal radiotherapy for irresectable Klatskin tumors.
    Schleicher UM, Staatz G, Alzen G, Andreopoulos D.
    Strahlenther Onkol; 2002 Dec 01; 178(12):682-7. PubMed ID: 12491056
    [Abstract] [Full Text] [Related]

  • 10. Concomitant chemoradiation treatment in the management of patients with extrahepatic biliary tract recurrence of gastric carcinoma.
    Lo SS, Wu CW, Chi KH, Tseng HS, Shen KH, Hsieh MC, Lui WY.
    Cancer; 2000 Jul 01; 89(1):29-34. PubMed ID: 10896997
    [Abstract] [Full Text] [Related]

  • 11. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
    Heron DE, Stein DE, Eschelman DJ, Topham AK, Waterman FM, Rosato EL, Alden M, Anne PR.
    Am J Clin Oncol; 2003 Aug 01; 26(4):422-8. PubMed ID: 12902899
    [Abstract] [Full Text] [Related]

  • 12. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E, Touboul E, Tiret E, Sezeur A, Hannoun L, Houry S, Huguet F, Pène F, Parc R, Schlienger M.
    Cancer Radiother; 2006 Dec 01; 10(8):572-82. PubMed ID: 17110148
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome.
    Milano MT, Chmura SJ, Garofalo MC, Rash C, Roeske JC, Connell PP, Kwon OH, Jani AB, Heimann R.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):445-53. PubMed ID: 15145161
    [Abstract] [Full Text] [Related]

  • 15. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma.
    Montemaggi P, Costamagna G, Dobelbower RR, Cellini N, Morganti AG, Mutignani M, Perri V, Brizi G, Marano P.
    Int J Radiat Oncol Biol Phys; 1995 May 15; 32(2):437-43. PubMed ID: 7538501
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE, Kaufman S, Cuttino L, DiPetrillo T, Arthur DW.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):489-95. PubMed ID: 16246495
    [Abstract] [Full Text] [Related]

  • 18. External-beam radiotherapy for localized extrahepatic cholangiocarcinoma.
    Ben-David MA, Griffith KA, Abu-Isa E, Lawrence TS, Knol J, Zalupski M, Ben-Josef E.
    Int J Radiat Oncol Biol Phys; 2006 Nov 01; 66(3):772-9. PubMed ID: 17011452
    [Abstract] [Full Text] [Related]

  • 19. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study.
    Válek V, Kysela P, Kala Z, Kiss I, Tomásek J, Petera J.
    Eur J Radiol; 2007 May 01; 62(2):175-9. PubMed ID: 17344008
    [Abstract] [Full Text] [Related]

  • 20. Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers: is it just for palliation?
    Montemaggi P, Morganti AG, Dobelbower RR, Brizi G, Smaniotto D, Costamagna G, Cellini N, Marano P.
    Radiology; 1996 Jun 01; 199(3):861-6. PubMed ID: 8638018
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.